CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Smoking Cessation

Discontinuing the habit of SMOKING.

Drugs by status

Approved for this indication (1)

  • cytisine

Phase 4 trials (7)

  • progesterone
  • nicotine
  • bupropion
  • medroxyprogesterone
  • varenicline
  • hydroxyzine
  • cytisinicline

Phase 3 trials (13)

  • oxytocin
  • lorcaserin
  • cycloserine
  • flutamide
  • topiramate
  • nicvax
  • propranolol
  • risperidone
  • rimonabant
  • dianicline
  • tropisetron
  • zonisamide
  • emb-01

Phase 2 trials (28)

  • simvastatin
  • buspirone
  • exenatide
  • centanafadine
  • suvorexant
  • encenicline
  • dulaglutide
  • folic acid
  • ganaxolone
  • gemfibrozil
  • liraglutide
  • naltrexone
  • guanfacine
  • insulin human
  • jnj-39393406
  • meclizine
  • nadolol
  • nalmefene
  • tobacco
  • sembragiline
  • sirolimus
  • acetylsalicylic acid
  • surinabant
  • x-22
  • autologous microbiome
  • dextromethorphan
  • fish oil
  • nfl-101

Phase 1 trials (10)

  • ketamine
  • sel-068
  • sela-070
  • isradipine
  • moxifloxacin
  • sodium chloride
  • sodium monododecyl sulfate
  • azd4041
  • ghrelin
  • sbp-9330

Other trials (5)

  • acetium
  • chlorzoxazone
  • ethanol
  • lactose
  • honey

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.